1. Home
  2. SVRA vs AMRC Comparison

SVRA vs AMRC Comparison

Compare SVRA & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • AMRC
  • Stock Information
  • Founded
  • SVRA 2007
  • AMRC 2000
  • Country
  • SVRA United States
  • AMRC United States
  • Employees
  • SVRA N/A
  • AMRC N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • AMRC Engineering & Construction
  • Sector
  • SVRA Health Care
  • AMRC Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • AMRC Nasdaq
  • Market Cap
  • SVRA 528.3M
  • AMRC 455.0M
  • IPO Year
  • SVRA N/A
  • AMRC 2010
  • Fundamental
  • Price
  • SVRA $2.06
  • AMRC $15.00
  • Analyst Decision
  • SVRA Buy
  • AMRC Hold
  • Analyst Count
  • SVRA 7
  • AMRC 7
  • Target Price
  • SVRA $7.57
  • AMRC $18.86
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • AMRC 444.8K
  • Earning Date
  • SVRA 08-11-2025
  • AMRC 08-04-2025
  • Dividend Yield
  • SVRA N/A
  • AMRC N/A
  • EPS Growth
  • SVRA N/A
  • AMRC N/A
  • EPS
  • SVRA N/A
  • AMRC 1.03
  • Revenue
  • SVRA N/A
  • AMRC $1,824,351,000.00
  • Revenue This Year
  • SVRA N/A
  • AMRC $8.59
  • Revenue Next Year
  • SVRA N/A
  • AMRC $9.78
  • P/E Ratio
  • SVRA N/A
  • AMRC $14.58
  • Revenue Growth
  • SVRA N/A
  • AMRC 30.13
  • 52 Week Low
  • SVRA $1.89
  • AMRC $8.49
  • 52 Week High
  • SVRA $5.11
  • AMRC $39.68
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 34.43
  • AMRC 51.66
  • Support Level
  • SVRA $2.13
  • AMRC $15.64
  • Resistance Level
  • SVRA $2.49
  • AMRC $16.62
  • Average True Range (ATR)
  • SVRA 0.15
  • AMRC 0.88
  • MACD
  • SVRA -0.01
  • AMRC -0.07
  • Stochastic Oscillator
  • SVRA 8.41
  • AMRC 51.65

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

Share on Social Networks: